1 recruiting. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Recruiting 1 |
Follow Communicable Diseases, Emerging: new trials by email Literature Review of Communicable Diseases, Emerging trials Research Report on Communicable Diseases, Emerging
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| BRAVO is a Phased Outbreak-response Study in the DRC Evaluating ERVEBO® Vaccination in ~20,000 Frontline Workers During the 2026 BDV Outbreak, Step A Assesses Real-world Effectiveness, Safety, and Impact on Severe Disease and Mortality, While Generating Evidence for Future BDV Vaccination Strategies ERVEBO Vaccination - Ebola, Bundibugyo Virus Disease (BVD) | Phase 4 | Recruiting | Epicentre | 20000 | 2026-09-19 | 2026-10-29 |
Communicable Diseases (1) · Disease Attributes (1) · Filoviridae Infections (1) · Hemorrhagic Fevers, Viral (1) · Infections (1) · Mononegavirales Infections (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · RNA Virus Infections (1) · Virus Diseases (1)
Epicentre (1)
Democratic Republic of the Congo (1)